Ophthalmology Times - Ophthalmic news, meetings and events, clinical studies, and clinical studies for

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Top Story
When amblyopia treatment fails, adherence is likely an issue
Parents of children with amblyopia may have several reasons (or excuses) for not following a prescribed patching regimen. Ophthalmologists who are following the Pediatric Eye Disease Investigator Group guidelines but are not achieving the desired results, should first examine whether patients are adhering to the prescribed therapy.

ADVERTISEMENT

Clinical News
Ophthalmic disorders linked to sleep disorders, finds research
November 20, 2008
Sleep disorders can be indicators of various unrecognized eye disorders, according to the results of a literature search reported in the November issue of Mayo Clinic Proceedings.
Distinct patterns of diabetic maculopathy seen on OCT
November 10, 2008
Optical coherence tomography (OCT) is valuable in managing diabetic macular edema (DME), more so than fluorescein angiography, in which the degree of leakage is not correlated with visual acuity and outcomes, according to Peter Kaiser, MD. In addition, angiography does not show vitreoretinal abnormalities that may require a different treatment.
Tips and techniques for cataract and refractive success: The dryeye connection
November 10, 2008
Dry eye disease and cataract and refractive surgery are intertwined closely. Pre-existing dry eye can affect surgical outcomes and, in severe cases, is a contraindication for surgery, whereas surgery causes trauma to the ocular surface and may lead to signs and symptoms of dry eye. To break this cycle, a two-pronged approach of treating dry eye before surgery and taking steps to prevent its development postoperatively is advisable.
Cataract surgery: Benefits on IOP more significant than realized
November 10, 2008
Instead of combined surgery, cataract extraction alone by phacoemulsification through a clear corneal incision with posterior chamber IOL implantation may be the most appropriate procedure for patients with controlled or modestly uncontrolled glaucoma as well as for patients with ocular hypertension or glaucoma suspects, said Richard L. Lindstrom, MD, in his delivery of the Kelman Lecture during the Spotlight on Cataract Surgery session of the annual meeting of the American Academy of Ophthalmology.
AAO: Simple measures improve cataract surgery outcomes for postLASIK
November 10, 2008
The difficulty of accurate IOL power calculation in postLASIK eyes is an issue being faced increasingly by cataract surgeons. Jack T. Holladay, MD, clinical professor of ophthalmology, Baylor College of Medicine, Houston, offered several tips for achieving better refractive outcomes in this growing population of eyes.
 More Articles
Industry News
Mini glaucoma shunt reimbursement increases under new classification
November 17, 2008
Optonol announced in a prepared statement that its proprietary mini glaucoma shunt (Ex-PRESS) will be paid under a new ambulatory payment classification (APC) beginning Jan. 1, 2009.
New drug application filed for bepotastine ophthalmic solution
November 17, 2008
ISTA Pharmaceuticals has filed a new drug application (NDA) with the FDA for bepotastine ophthalmic solution (Bepreve). If approved, the solution would be used as an eye drop treatment for ocular itching associated with allergic conjunctivitis.
Strong attendance seen at AAO and SOE joint meeting
November 17, 2008
The American Academy of Ophthalmology (AAO) 2008 joint meeting with the European Society of Ophthalmology, held in Atlanta Nov. 8 to 11, featured strong attendance numbers. Preliminary figures for attendance at the meeting were approximately 22,000, and attendance at the Subspecialty Day events Nov. 7 and 8 totaled more than 6,200.
PBA receives $1 million grant from CDC
November 15, 2008
Prevent Blindness America (PBA) announced it has been awarded a 3-year cooperative agreement from the Centers for Disease Control and Prevention (CDC), with a first-year grant of $1 million.
Advanced Medical Optics viscosurgical device receives FDA approval
November 15, 2008
Advanced Medical Optics (AMO) announced that the FDA has granted premarket approval of a clear dispersive ophthalmic viscosurgical device (OVD) (Healon D) for use as a surgical aid in cataract extraction, IOL implantation, corneal transplant, and glaucoma filtration surgery.
 More Articles
Practice Management
Beyond intelligence, look for potential employees with 'wanna' when hiring
Once you get employees to realize that their success or failure ultimately is up to them, the pressure is off you as a manager. The pressure is squarely in the place it needs to be: on the employees. Your only job then becomes augmenting their growth with the tools they need to be the hardest-working technicians you ever will have.

ADVERTISEMENT

Ophthalmology Times issue
Stay connected to Ophthalmology Times
Receive new issue alerts, technology bulletins, and conference updates!
What Do You Think?
What is your favorite host city for the annual meeting of the American Academy of Ophthalmology?
A. Atlanta
B. Chicago
C. New Orleans
D. San Francisco
E. Other
A. Atlanta
5%
B. Chicago
23%
C. New Orleans
16%
D. San Francisco
42%
E. Other
14%
View Results

ADVERTISEMENT

Click here